GINKGO BIOWORKS HOLDINGS, INC. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2026-08-06: Form 10-Q; Item Shares outstanding CommonClassA as of 2026-07-31; As filed 55,383,808.
- 2026-08-06: Form 10-Q; Item Shares outstanding CommonClassB as of 2026-07-31; As filed 8,956,469.
- 2026-08-06: Form 10-Q; Item Shares outstanding NonvotingCommonStock as of 2026-07-31; As filed 3,000,000.
- 2026-05-07: Form 10-Q; Item Shares outstanding CommonClassA as of 2026-04-30; As filed 53,361,141.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2026-08-06 | 10-Q | Shares outstanding CommonClassA as of 2026-07-31 | 55,383,808 |
| 2026-08-06 | 10-Q | Shares outstanding CommonClassB as of 2026-07-31 | 8,956,469 |
| 2026-08-06 | 10-Q | Shares outstanding NonvotingCommonStock as of 2026-07-31 | 3,000,000 |
| 2026-05-07 | 10-Q | Shares outstanding CommonClassA as of 2026-04-30 | 53,361,141 |
| 2026-05-07 | 10-Q | Shares outstanding CommonClassB as of 2026-04-30 | 8,963,350 |
| 2026-05-07 | 10-Q | Shares outstanding NonvotingCommonStock as of 2026-04-30 | 3,000,000 |
| 2026-02-26 | 10-K | Shares outstanding CommonClassA as of 2026-02-16 | 49,941,878 |
| 2026-02-26 | 10-K | Shares outstanding CommonClassB as of 2026-02-16 | 8,982,474 |
| 2026-02-26 | 10-K | Shares outstanding NonvotingCommonStock as of 2026-02-16 | 3,000,000 |
| 2025-11-06 | 10-Q | Shares outstanding CommonClassA as of 2025-10-31 | 48,523,595 |
| 2025-11-06 | 10-Q | Shares outstanding CommonClassB as of 2025-10-31 | 9,066,624 |
| 2025-11-06 | 10-Q | Shares outstanding NonvotingCommonStock as of 2025-10-31 | 3,000,000 |
| 2025-08-07 | 10-Q | Shares outstanding CommonClassA as of 2025-07-31 | 47,089,598 |
| 2025-08-07 | 10-Q | Shares outstanding CommonClassB as of 2025-07-31 | 9,110,155 |
| 2025-08-07 | 10-Q | Shares outstanding NonvotingCommonStock as of 2025-07-31 | 3,000,000 |
| 2025-05-06 | 10-Q | Shares outstanding CommonClassA as of 2025-04-30 | 46,344,630 |
| 2025-05-06 | 10-Q | Shares outstanding CommonClassB as of 2025-04-30 | 9,187,247 |
| 2025-05-06 | 10-Q | Shares outstanding NonvotingCommonStock as of 2025-04-30 | 3,000,000 |
| 2025-02-25 | 10-K | Shares outstanding CommonClassA as of 2025-02-17 | 45,808,499 |
| 2025-02-25 | 10-K | Shares outstanding CommonClassB as of 2025-02-17 | 9,225,101 |
| 2025-02-25 | 10-K | Shares outstanding NonvotingCommonStock as of 2025-02-17 | 3,000,000 |
| 2025-02-25 | 10-K | Public float as of 2024-06-28 | $617.00M |
| 2024-11-12 | 10-Q | Shares outstanding CommonClassA as of 2024-10-31 | 45,199,331 |
| 2024-11-12 | 10-Q | Shares outstanding CommonClassB as of 2024-10-31 | 9,279,574 |
| 2024-11-12 | 10-Q | Shares outstanding NonvotingCommonStock as of 2024-10-31 | 3,000,000 |
| 2024-08-08 | 10-Q | Shares outstanding CommonClassA as of 2024-08-01 | 1,724,120,468 |
| 2024-08-08 | 10-Q | Shares outstanding CommonClassB as of 2024-08-01 | 378,894,930 |
| 2024-08-08 | 10-Q | Shares outstanding NonvotingCommonStock as of 2024-08-01 | 120,000,000 |
| 2024-08-08 | 10-Q | Stock registered under Section 12(b) | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share · DNA.WS · NYSE |
| 2024-05-09 | 10-Q | Shares outstanding CommonClassA as of 2024-05-02 | 1,709,063,953 |
| 2024-05-09 | 10-Q | Shares outstanding CommonClassB as of 2024-05-02 | 382,214,015 |
| 2024-05-09 | 10-Q | Shares outstanding NonvotingCommonStock as of 2024-05-02 | 120,000,000 |
| 2024-05-09 | 10-Q | Stock registered under Section 12(b) | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share · DNA.WS · NYSE |
| 2024-02-29 | 10-K | Shares outstanding CommonClassA as of 2024-02-22 | 1,650,909,109 |
| 2024-02-29 | 10-K | Shares outstanding CommonClassB as of 2024-02-22 | 381,486,677 |
| 2024-02-29 | 10-K | Shares outstanding NonvotingCommonStock as of 2024-02-22 | 120,000,000 |
| 2024-02-29 | 10-K | Stock registered under Section 12(b) | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share · DNA.WS · NYSE |
| 2023-11-08 | 10-Q | Shares outstanding CommonClassA as of 2023-10-31 | 1,619,442,071 |
| 2023-11-08 | 10-Q | Shares outstanding CommonClassB as of 2023-10-31 | 378,994,485 |
| 2023-11-08 | 10-Q | Shares outstanding NonvotingCommonStock as of 2023-10-31 | 120,000,000 |
| 2023-11-08 | 10-Q | Stock registered under Section 12(b) | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share · DNA.WS · NYSE |
| 2023-08-09 | 10-Q | Shares outstanding CommonClassA as of 2023-07-31 | 1,600,988,177 |
| 2023-08-09 | 10-Q | Shares outstanding CommonClassB as of 2023-07-31 | 377,864,805 |
| 2023-08-09 | 10-Q | Stock registered under Section 12(b) | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share · DNA.WS · NYSE |
| 2023-05-10 | 10-Q | Shares outstanding CommonClassA as of 2023-05-05 | 1,585,286,502 |
| 2023-05-10 | 10-Q | Shares outstanding CommonClassB as of 2023-05-05 | 380,212,951 |
| 2023-05-10 | 10-Q | Shares outstanding CommonClassC as of 2023-05-05 | 120,000,000 |
| 2023-05-10 | 10-Q | Stock registered under Section 12(b) | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share · DNA.WS · NYSE |
| 2023-03-13 | 10-K | Shares outstanding CommonClassA as of 2023-03-02 | 1,570,064,412 |
| 2023-03-13 | 10-K | Shares outstanding CommonClassB as of 2023-03-02 | 382,516,010 |
| 2023-03-13 | 10-K | Stock registered under Section 12(b) | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share · DNA.WS · NYSE |
| 2022-11-14 | 10-Q | Shares outstanding CommonClassA as of 2022-11-07 | 1,354,642,123 |
| 2022-11-14 | 10-Q | Shares outstanding CommonClassB as of 2022-11-07 | 385,337,742 |
| 2022-11-14 | 10-Q | Shares outstanding CommonClassC as of 2022-11-07 | 200,000,000 |
| 2022-11-14 | 10-Q | Stock registered under Section 12(b) | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share · DNA.WS · NYSE |
| 2022-11-14 | 10-Q | Emerging growth company | Yes |
| 2022-09-01 | 10-K/A | Shares outstanding CommonClassA as of 2022-03-17 | 1,080,456,818 |
| 2022-09-01 | 10-K/A | Shares outstanding CommonClassB as of 2022-03-17 | 391,147,458 |
| 2022-09-01 | 10-K/A | Shares outstanding NonVotingClassCCommonStock as of 2022-03-17 | 288,000,000 |
| 2022-09-01 | 10-K/A | Stock registered under Section 12(b) | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share · DNA.WS · NYSE |
| 2022-09-01 | 10-K/A | Emerging growth company | Yes |
| 2022-09-01 | 10-K/A | Well-known seasoned issuer | Yes |
| 2022-08-15 | 10-Q | Shares outstanding CommonClassA as of 2022-08-08 | 1,099,693,341 |
| 2022-08-15 | 10-Q | Shares outstanding CommonClassB as of 2022-08-08 | 397,139,476 |
| 2022-08-15 | 10-Q | Shares outstanding CommonClassC as of 2022-08-08 | 288,000,000 |
| 2022-08-15 | 10-Q | Stock registered under Section 12(b) | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share · DNA.WS · NYSE |
| 2022-08-15 | 10-Q | Emerging growth company | Yes |
| 2022-05-16 | 10-Q | Shares outstanding CommonClassA as of 2022-05-09 | 1,093,522,711 |
| 2022-05-16 | 10-Q | Shares outstanding CommonClassB as of 2022-05-09 | 395,114,230 |
| 2022-05-16 | 10-Q | Shares outstanding CommonClassC as of 2022-05-09 | 288,000,000 |
| 2022-05-16 | 10-Q | Stock registered under Section 12(b) | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share · DNA.WS · NYSE |
| 2022-05-16 | 10-Q | Emerging growth company | Yes |
| 2022-03-29 | 10-K | Shares outstanding CommonClassA as of 2022-03-17 | 1,080,456,818 |
| 2022-03-29 | 10-K | Shares outstanding CommonClassB as of 2022-03-17 | 391,147,458 |
| 2022-03-29 | 10-K | Stock registered under Section 12(b) | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share · DNA.WS · NYSE |
| 2022-03-29 | 10-K | Emerging growth company | Yes |
| 2021-11-15 | 10-Q | Shares outstanding CommonClassA as of 2021-11-08 | 1,188,712,411 |
| 2021-11-15 | 10-Q | Shares outstanding CommonClassB as of 2021-11-08 | 298,021,863 |
| 2021-11-15 | 10-Q | Stock registered under Section 12(b) | Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share · DNA.WS · NYSE |
| 2021-11-15 | 10-Q | Emerging growth company | Yes |
| 2021-08-16 | 10-Q | Shares outstanding CommonClassA as of 2021-08-16 | 172,500,000 |
| 2021-08-16 | 10-Q | Shares outstanding CommonClassB as of 2021-08-16 | 43,125,000 |
| 2021-08-16 | 10-Q | Stock registered under Section 12(b) | Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant · SRNGU · NASDAQ |
| 2021-08-16 | 10-Q | Stock registered under Section 12(b) | Class A ordinary shares, par value $0.0001 per share · SRNG · NASDAQ |
| 2021-08-16 | 10-Q | Stock registered under Section 12(b) | Warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share · SRNGW · NASDAQ |
| 2021-08-16 | 10-Q | Shell company | Yes |
| 2021-08-16 | 10-Q | Emerging growth company | Yes |
| 2021-05-24 | 10-Q | Stock registered under Section 12(b) | Units, each consisting of one Class A ordinary share and one-fifth of one redeemable warrant · SRNGU · NASDAQ |
| 2021-05-24 | 10-Q | Stock registered under Section 12(b) | Class A ordinary shares, par value $0.0001 per share · SRNG · NASDAQ |
| 2021-05-24 | 10-Q | Stock registered under Section 12(b) | Warrants, each whole warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share · SRNGW · NASDAQ |
| 2021-05-24 | 10-Q | Shell company | Yes |
| 2021-05-24 | 10-Q | Emerging growth company | Yes |